Company profile
Ticker
ATHXQ
Exchange
Website
CEO
Gil Van Bokkelen
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
BTHC VI Inc
SEC CIK
Corporate docs
Subsidiaries
ABT Holding Company • Advanced Biotherapeutics, Inc. • Athersys Limited • ReGenesys LLC • ReGenesys BV • ReGenesys EU NV ...
ATHXQ stock data
Latest filings (excl ownership)
8-K
Entry into a Material Definitive Agreement
5 Apr 24
NT 10-K
Notice of late annual filing
1 Apr 24
8-K
Entry into a Material Definitive Agreement
8 Jan 24
25-NSE
Exchange delisting
27 Dec 23
8-K
Cost Associated with Exit or Disposal Activities
22 Dec 23
424B3
Prospectus supplement
4 Dec 23
EFFECT
Notice of effectiveness
30 Nov 23
CORRESP
Correspondence with SEC
28 Nov 23
S-1/A
IPO registration (amended)
21 Nov 23
10-Q
2023 Q3
Quarterly report
16 Nov 23
Transcripts
ATHXQ
Earnings call transcript
2022 Q3
15 Nov 22
ATHXQ
Earnings call transcript
2022 Q2
12 Aug 22
ATHXQ
Earnings call transcript
2021 Q4
16 Mar 22
ATHXQ
Earnings call transcript
2021 Q3
16 Nov 21
ATHXQ
Earnings call transcript
2021 Q2
10 Aug 21
ATHXQ
Earnings call transcript
2021 Q1
9 May 21
ATHXQ
Earnings call transcript
2021 Q1
6 May 21
ATHXQ
Earnings call transcript
2020 Q3
9 Nov 20
ATHXQ
Earnings call transcript
2020 Q3
9 Nov 20
ATHXQ
Earnings call transcript
2020 Q2
10 Aug 20
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | |||
---|---|---|---|---|---|---|
Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q | |
Cash on hand (at last report) | 1.02 mm | 1.02 mm | 1.02 mm | 1.02 mm | 1.02 mm | 1.02 mm |
Cash burn (monthly) | 261.00 k | 1.06 mm | 2.59 mm | 3.48 mm | 1.28 mm | 2.20 mm |
Cash used (since last report) | 4.37 mm | 17.81 mm | 43.42 mm | 58.27 mm | 21.47 mm | 36.78 mm |
Cash remaining | -3.35 mm | -16.79 mm | -42.40 mm | -57.25 mm | -20.45 mm | -35.76 mm |
Runway (months of cash) | -12.8 | -15.8 | -16.4 | -16.5 | -15.9 | -16.3 |
Institutional ownership, Q3 2024
13F holders | Current |
---|---|
Total holders | 2 |
Opened positions | 2 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 347.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
McMahon Financial Advisors | 227.00 | $0.00 |
Game Plan Financial Advisors | 120.00 | $0.00 |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
18 Dec 23 | Hansen Maia | Common Stock | Payment of exercise | Dispose F | No | No | 0.025 | 67 | 1.68 | 70,010 |
4 Oct 23 | Daniel A. Camardo | Common Stock | Payment of exercise | Dispose F | No | No | 0.44 | 19,993 | 8.80 k | 285,341 |
4 Oct 23 | Hansen Maia | Common Stock | Payment of exercise | Dispose F | No | No | 0.44 | 23,149 | 10.19 k | 70,144 |
18 Sep 23 | Hansen Maia | Common Stock | Payment of exercise | Dispose F | No | No | 0.3 | 67 | 20.10 | 77,170 |